Sign inJoin Free
DashboardSign out
Free Lesson Preview
Module 1: Lesson 1
Randomization and unblinding
Master the investigator's responsibilities for maintaining randomization integrity, protecting blinding throughout trial conduct, and executing emergency unblinding procedures when participant safety requires it.
Randomization and unblinding
At 2:47 AM, the on-call physician at a Phase III trial site receives an urgent page. A participant has arrived at the emergency department with severe respiratory distress. The treating physician needs to know immediately: Is this participant on the active treatment or placebo? The answer will guide critical decisions about potential drug interactions and treatment approaches. Somewhere in the site's files is a sealed envelope that contains this information. But should it be opened?
This scenario—which occurs far more often than most researchers anticipate—captures the tension at the heart of Section 2.11. Randomization protects the science; blinding prevents bias from corrupting results. Yet participant safety must never be sacrificed for methodological purity. The investigator's challenge is knowing when the code must remain sealed and when breaking it is not just permitted but obligatory.
I have observed that sites often prepare elaborate unblinding procedures but rarely practice them. When the 2:47 AM call comes, fumbling through unfamiliar documentation while a participant struggles to breathe is not adequate. The procedures you will learn in this lesson must become second nature—understood so thoroughly that executing them during a crisis requires no deliberation.
Section 2.11 of ICH E6(R3) Annex 1 establishes the framework: follow the protocol's randomization procedures, maintain blinding integrity, and break the code only when the protocol permits or participant safety demands.
What you will learn
By the end of this lesson, you will be able to:
Good Clinical Practice (GCP)
Full course · ICH E6(R3) Principles